Metabolic Syndrome
Weight loss reduces circulating ADMA concentrations in morbidly obese women
Published in Obesity and Diabetes Week, February 14th, 2005
K. Krzyzanowska and colleagues, University Hospital Rudolf Virchow, Vienna, Austria, wrote, "The endogenous nitric oxide-synthase inhibitor asymmetrical dimethyl-L-arginine (ADMA) is elevated in patients with increased risk for arteriosclerosis. Obesity is a risk factor for cardiovascular disease. We measured plasma ADMA concentrations in morbidly obese women before and after weight loss following gastroplastic surgery.
"ADMA and symmetrical dimethyl-L-arginine concentrations were analyzed by HPLC from 34 female patients (age...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
More Articles from Obesity and Diabetes Week
- Diabetes Pathogenesis
Linkage analysis conducted of diabetes among hypertensive families - Diabetes Therapy
Researchers' work adds to diabetes therapy body of knowledge - Diabetes Therapy
Structure of GIP fragment determined - Diabetic Cardiomyopathy
Hyperglycemia produces cardiac abnormalities in rats fed PUFA-rich diet - Obesity and Diabetes
Effective treatments for insulin resistance reviewed - Obesity and Diabetes
Palmitate induces IL-6 expression in coronary artery endothelial cells - More from this issue of Obesity and Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
